Shri J P Nadda, Minister of Health and Family Welfare held a review meeting with senior officials of Health Ministry in the backdrop of recent outbreak of Japanese Encephalitis (JE) in Assam. He stated that the Director General of Health Services has been directed to immediately rush a team of experts to Assam to assist and advise the State health authorities in clinical management of the cases.
Bureau of Pharma PSUs of India (BPPI) is to provide Rs. 2.5 lakhs help for seeting up your Jan Aushadhi Stores (JAS). Any NGO/Charitable Society/Institution/Self Help Group can also open the Jan Aushadhi store outside the hospital premises.
Telangana government has embarked on ‘e-arogyam’, an online e-medicine centre in all the government hospitals. The main aim of this programme is to provide quality healthcare services to poor patients in the rural areas.
On World Population Day, Shri J P Nadda, Minister for Health & Family Welfare suggested the idea of taking up the task of population stabilisation in the country by adopting a Mission Mode approach, where focused and targeted work in taken up in those states where the figures have been high.
The Andhra Pradesh government has launched a new software application ‘e-Aushadini’ to manage stocks of various drugs in government hospitals. The main aim of 'e-Aushadini' is to ascertain the needs of various district drug warehouses such that all the required materials/drugs are constantly available to be supplied to the user district drug warehouses without delay.
Arogya Finance, a social healthcare venture, has launched the Arogya Card in Mumbai. The Arogya Card is a a pre-approved medical loan of upto Rs.2 lakh for the cardholders and their family members.
On the occasion of the visit of Dutch Prime Minister Mark Rutte to India, the two countries have decided to expand their existing cooperation in the area of large scale cohort studies with a Joint Cohort study on HIV patients in India.
Cluster Development Programme for Pharma Sector (CDS-PS) is launched by Government to provide support to the Pharmaceutical industry in becoming more capable, productive and competitive. End of this financial year, 06 Pharma Clusters are likely to come up of which 03 will be greenfields.
[adsense:336x280:8701650588]
Under “Make in India” initiative India and the Netherlands have signed a Memorandum of Understanding for the development of vaccines. The MoU was signed between visiting Prime Minister of Netherlands Mark Rutte and government of India in New Delhi. This cooperation between the two countries in the vaccine manufacturing segment is expected to result in large scale production of measles-rubella and other needed vaccine in the country. The ‘Make in India’ is a critical initiative for promoting access to health technology beyond the borders of India.
The Indian Council on Medical Research (ICMR) and the National Institutes of Health (NIH), US, will soon begin collaborative research on ‘Prevention of Sexually Transmitted Diseases & HIV/AIDS’. The joint research programme will also have thrust on HIV and AIDS-associated co-morbidities. Under this, the focus will be on utilsation of new/enhanced therapeutics for HIV-related co-morbidities such as HCV and their impact on disease outcomes; and enhanced targeted outreach strategies for HCV testing, prevention, and treatment/care engagement; integrated approaches for addressing the complex bio-behavioral factors associated with HCV/HIV. In this regard a joint Indo-US workshop is proposed to be held in September 2015 to encourage investigators for the Indo-US collaborative projects. Under translational research, the focus will be on studies to develop and test innovative HIV prevention strategies in young populations, particularly adolescents; and also on studies to better understand linkages between reproductive health options and HIV infection in men and women.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
